India's hospital sector enters new growth cycle as AI and capacity expansion reshape care: Report The Times of India 1d The Times of India 1d
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for Pd-L1-positive NSCLC Accepted for Review by NMPA PR Newswire (Press Release) 3d PR Newswire (Press Release) 3d
Nuclera launches antibody triage service to advance AI-driven antibody discovery Business Wire (Press Release) 3h Business Wire (Press Release) 3h
ACROBiosystems upgrades HEK293 licence solution for R&D compliance Pharmaceutical Business Review 10:51
Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers PR Newswire (Press Release) 10:11
STAT Plus: Five years after disaster, a rare disease community gets new chance at treatment STAT 09:34
Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery Business Wire (Press Release) 09:22